The Mets have a one-year agreement with infielder Nick Madrigal, the club announced. It’s reportedly a split deal that pays the Wasserman client $1.35MM in the majors, with another $500K ...

Madrigal Pharmaceuticals announced its preliminary Q4 and full-year results. The company topped the official Wall Street estimates, but seems to have missed the so-called "whisper numbers ...

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were sinking 13.3% lower as of 11:11 a.m. ET on Monday. The sell-off came after the drugmaker announced its preliminary fourth-quarter and full ...

Looking to add to their infield depth, the New York Mets agreed to a one-year deal with veteran Nick Madrigal on Friday, league sources confirmed. The New York Post first reported the agreement.

NEW YORK (AP) — The New York Mets signed infielder Nick Madrigal to a one-year contract Friday. Madrigal hit .221 with 10 RBIs in 51 games for the Chicago Cubs last year. He was non-tendered by ...

Analyst Jonathan Wolleben of JMP Securities reiterated a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report), with a price target of $427.00. Discover outperforming stocks and invest ...

CONSHOHOCKEN, Pa., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction ...

Madrigal, who will turn 28-years-old in March, was the fourth overall pick in the 2018 MLB Draft by the Chicago White Sox. However, he has yet to pan out as a big-leaguer and has dealt with three ...